Top Amwell Alternatives, Competitors & Similar Software

Neurodiversity Cognitive Assessment Software

WCG is a true partner to research sponsors, CROs, sites and participants in navigating the clinical research journey. The pioneer of independent ethical review, now the industry gold standard, WCG’s 55-year legacy of independent review solutions serves as the foundation on which we continually build to accelerate and improve the clinical research journey. We lead the way by reimagining processes, optimizing quality and safety, strengthening productivity, and pioneering new solutions that leverage data and technology to accelerate research and impact global health. WCG liberates study stakeholders from the constraints that risk trial efficacy while improving quality outcomes and efficiency through the process. Ninety percent of all clinical trials leverage our knowledge, highly specialized solutions, and data-driven insights to mitigate risk today for a more promising tomorrow.

Neurodiversity Cognitive Assessment Software

The brain is central to every aspect of our lives, yet it isn’t monitored with the same consistency and proactivity as other vital signs. As a neuroscience technology company, we believe that better brain health insights lead to better brain health outcomes. That's why we're on a mission to democratize cognitive health by radically simplifying the way it is measured. For more than 20 years, we’ve proudly supported the research needs of biopharmaceutical companies and academic institutions, and the clinical care needs of physicians and individuals around the world. We create easy to use digital tests that provide rapid, reliable, and science-backed results and offer solutions that support the highest fidelity measurements possible. We believe our team members should have flexibility as to how, when, and where they work. We work flexibly to support our global team, who mostly work from home––and offer opportunities for face-to-face collaboration at our offices in New Haven, Melbourne, and London. Our team members also have access to co-working spaces around the world.

Neurodiversity Cognitive Assessment Software

Navigate360 is the leading provider of safety solutions for schools, leading to enhanced student well-being. With more than 20 years of experience, our multifaceted, layered approach—providing everything from curricula that support positive behavior and self-image to campus physical safety and personnel training—focuses on incident prevention. Currently, more than 14 million students are using Navigate360 solutions.

Neurodiversity Cognitive Assessment Software

As a global patient agency and strategic partner to pharmaceutical and life sciences companies, Atlantis Health co-designs and delivers personalized patient engagement solutions using the latest behavioral science and technology. We empower people to manage their treatment and the challenges faced across their health journey, improving outcomes and impact. We are a global group of companies with offices in the United States, United Kingdom, Germany, Australia and New Zealand. Since 1996, we have helped our clients to achieve their patient engagement and behavior change objectives, provide better patient experiences, and gain valuable real-world data and insights. Our multichannel patient engagement solutions help people across more than 30 countries in over 100 different health conditions ranging from ultra-rare and orphan diseases to more common conditions such as cancer, type 2 diabetes and asthma.

Neurodiversity Cognitive Assessment Software

Creyos (formerly Cambridge Brain Sciences) is a leading web-based platform for the assessment of brain health. It allows you to obtain accurate, quantified and scientifically-validated measures of key aspects of cognition, including short-term memory, attention, reasoning, and verbal ability. Creyos offers two core products – Creyos Health and Creyos Research. Built for health care practitioners, Creyos Health is an online brain health assessment service that takes seconds to set up, is engaging and enjoyable for patients, and produces a reliable and scientifically-validated cognitive assessment report in as little as 15 minutes. It is used by leading health care clinics around the world to track brain health over time as part of cognitive treatment and wellness plans. Healthcare providers using Creyos Health also have access to digital versions of many standardized patient health questionnaires. Creyos Research is made for researchers running studies on cognition in academic and commercial settings, allowing for the collection of cognitive data at scale. It has been used by many leading institutions, including Baycrest, Pfizer and Roche. Both products allow for assessment customization and online administration, require no expert technical support to administer and enable you to store and manage cognitive data securely in the cloud. Creyos maintains a global normative database of more than 85,000 participants (built off of our larger database of 12+ million completed cognitive tasks) that enables you to derive detailed comparisons of individuals to specific populations. The Cambridge Brain Sciences (now Creyos) cognitive tasks were developed in the laboratory of Dr. Adrian Owen, Canada Excellence Research Chair in Cognitive Neuroscience and Imaging (owenlab.org), over the course of his 25-year career. Over 300 scientific studies have been run to date using our tests, yielding numerous publications in leading academic journals.

Neurodiversity Cognitive Assessment Software

Cambridge Cognition Holdings PLC is a neuroscience digital health company specializing in the precise measurement of clinical outcomes in neurological disorders. The company product segments include Software, Services, and Hardware. It generates maximum revenue from the Software segment. Geographically, it derives majority revenue from the United States of America and also has a presence in the United Kingdom, European Union and Rest of world. The company services include Neuroscience consultancy, Technical consultancy, Study design, Data analysis, Study management, Data management, and Reports and interpretation.

Neurodiversity Cognitive Assessment Software

GL Assessment is a global leader in education technology with a clear mission: to accelerate learning for all children and adults of all ability levels and ethnic and social backgrounds, worldwide. GL Assessment, which has been a Renaissance company since 2023, has helped teachers assess students’ strengths and challenges in learning, identify and support children with additional educational needs, and provide schools with evidence of progress for over 40 years. Today, schools in over 100 countries rely on our assessments to make informed decisions about their students' educational journey. From its beginnings in 1986, Renaissance has grown to become a global leader in education technology. Each year millions of books are read and online assessments completed by tens of thousands of schools around the world using Renaissance solutions. Together, GL and Renaissance are creating something new: a connected suite of products that help teachers accurately identify student needs and adapt teaching to ensure all students build the skills they need for success. And all of this is based on technology that allows schools and school groups to deliver accelerated learning. Our combined strengths allow us to give schools exactly what they need, when they need it. Teachers trust our established products – from CAT4 to Accelerated Reader – because they work. We can offer more support, better solutions and deeper analysis of what makes a difference in education. Every solution we create still aims to make teaching more effective and learning more achievable. Our approach ensures schools get the support they need, when they need it.

Neurodiversity Cognitive Assessment Software

Lumosity is a leading brain training program, brought to you by Lumos Labs, Inc. Lumosity’s web and mobile games are designed by scientists to challenge core cognitive abilities. Lumosity’s scientists take neuropsychological and cognitive research tasks, or design new ones, and work with game designers to transform them into 50+ cognitive games. Designed to be both fun and adaptively challenging, Lumosity’s training program is accessible to people of all ages — helping them stay challenged to the full extent of their abilities. Lumos Labs also has a collaborative research initiative, the Human Cognition Project, which currently partners with over 90 university collaborators. Through the HCP, we grant qualified researchers free access to Lumosity’s cognitive training tasks, assessments, research tools, and, in some cases, limited access to data on cognitive task performance — helping them conduct larger, faster, and more efficient studies. For more information, please visit http://www.lumosity.com/hcp

Neurodiversity Cognitive Assessment Software

CogniFit is a global leader in digital health, dedicated to advancing cognitive wellness through cutting-edge technology and scientifically validated solutions. With over 25 years of collaboration with leading institutions and a strong foundation in peer-reviewed research, CogniFit has established itself as a trusted innovator in cognitive assessment and brain training. Our patented technology is meticulously designed to evaluate and enhance 22 critical cognitive domains covering memory, attention, perception, coordination, and executive functions. By seamlessly integrating scientific rigor with user-friendly interfaces, CogniFit empowers users to optimize their cognitive potential at any stage of life. Available on both desktop and mobile platforms (iOS and Android), CogniFit ensures accessibility and convenience for users worldwide. With support in 18 languages, we aim to break barriers and bring cognitive health to diverse populations. For professionals, CogniFit offers dedicated platforms tailored to their unique needs. These tools enable the assessment, training, monitoring, and tracking of cognitive skills, providing actionable insights to enhance patient care, employees mental wellness, educational outcomes, and research initiatives: - Healthcare: www.cognifit.com/medical-platform - Clinical Trials: www.cognifit.com/clinical-trials - Education: www.cognifit.com/educational-technology - Research: www.cognifit.com/cognitive-research-tool - Corporate Wellbeing: www.cognifit.com/employee-wellbeing - Nursing Homes: www.cognifit.com/nursing-homes - API For Developers: www.cognifit.com/developers Through strategic partnerships in the health, wellness, and educational sectors, CogniFit is shaping the future of cognitive health, helping individuals and organizations unlock their full potential. Join us on this journey to redefine how we care for and cultivate the human mind.

Neurodiversity Cognitive Assessment Software

Wir bieten mit dem Whole Brain® Thinking-Modell, dem HBDI® (Herrmann Brain Dominance Instrument®) und weiteren Tools – wie dem Whole Brain® Walkaround, dem Teamdiagnostik-Tool oder unseren ‟Business of Thinking”-Modulen – Instrumente zur Potenzialanalyse, Team- und Unternehmensentwicklung. Diese werden von Trainern, Coaches, Führungskräften und Personalverantwortlichen eingesetzt: • In der Personal-, Führungskräfte-, Team- und Organisationsentwicklung • Zur Verbesserung von Innovations- und Kreativitätsprozessen • In Kommunikations-und Verkaufstrainings • Im Projekt-/Change-Management • In Marketing und Vertrieb • In der Produktentwicklung • Im Recruiting Das Herz von Whole Brain® Thinking ist die HBDI®-Denkstilanalyse. Sie zeigt Potenziale und Stärken, wie auch Vermeidungstendenzen und Defizite – für einzelne Personen und Teams. Die Denkstile der Mitglieder eines Teams haben großen Einfluss auf die Arbeitsweise und die Zusammenarbeit im Team. Das HBDI®-Teamprofil veranschaulicht diese und eröffnet eine positive und nachhaltige Teamentwicklung: • Stärken, Synergien und Potenziale werden sichtbar, aber auch mögliche Reibungsverluste und Defizite. • Die Teammitglieder lernen von unterschiedlichen Denkstilen zu profitieren, diese zu schätzen und sich gegenseitig zu ergänzen. • Die Kommunikation im Team wird einfacher und die Aufgaben können leichter den Stärken der Mitglieder entsprechend verteilt werden. • Die Teammotivation und -effizienz wird erhöht. Die Logik des Modells lässt sich auf Aufgabenstellungen übertragen. So können Profile für Aufgabengebiete, Produkte/Leistungen, Zielgruppen, Veränderungsprozesse oder für eine Unternehmenskultur angefertigt werden. Unsere Leistungen umfassen: • HBDI®-Einzel-, Zwei-Personen- und Teamprofile • Workshops, (Inhouse-) Seminare • Zertifizierung zum autorisierten HBDI®-Anwender • Für Unternehmen gibt es eine große Auswahl an Beratungsleistungen. • Für Trainer und Coaches stehen eigene Workshop-Module zur Verfügung.

Neurodiversity Cognitive Assessment Software

Psychology Software Tools, Inc. was founded with the vision of creating innovative and affordable technologies and solutions which improve the efficacy of human behavioral research, assessment, and education. Our goal is to consistently provide products and services to our customers which increase their productivity, effectiveness, and confidence in addressing the challenges they face in these diverse disciplines. To realize this vision, we emphasize a focus on research and development activities, employee expertise, quality, and customer satisfaction.

Neurodiversity Cognitive Assessment Software

Through research and innovation, we provide for the most accurate assessment of cognitive performance. Our leading cognitive screening tools result in early diagnoses and treatment plans to improve brain health and well-being. Our mission is fuelled by our passionate belief that everyone deserves a memorable life. 𝗪𝗵𝗼 𝘂𝘀𝗲𝘀 𝗠𝗼𝗖𝗔? Family Practice Physicians Nurses Psychologists Speech-Language Pathologists Occupational Therapists Neurologists Geriatricians And more 𝗧𝗿𝘆 𝗼𝘂𝗿 𝗳𝗿𝗲𝗲 𝗠𝗼𝗖𝗔 𝗗𝗨𝗢 𝗮𝗽𝗽 𝗳𝗼𝗿 𝘁𝗮𝗯𝗹𝗲𝘁: https://mocacognition.com/digitaltools/

Neurodiversity Cognitive Assessment Software

In a world where Neurological disorders will affect 1 person in 3 and where the number of parkinson's patient will double in the next decade, reaching 13 million patients. Our mission is to empower clinicians with Biomarkers allowing them to identify Neurological Disorders (Parkinson's Disease, Alzheimer's Disease and Multiple Sclerosis) years before visible symptoms. Our ambition with NeuroClues is to become the brain's stethoscope. We are a team of seasoned MedTech entrepreneurs and doctors with as purpose to help our healthcare system cross the chasm of technology with pragmatic solutions. We work from anywhere but our base camps are in Louvain-la-Neuve, Belgium & Paris, France & NY, USA. We’re are looking to connect with individuals, companies, investors and Key Opinion Leaders that share our ambition and mission and that would be willing to partner with us in order to bring NeuroClues to the EU and US market.

Neurodiversity Cognitive Assessment Software

We provide best in class concussion care to patients worldwide. Since 2002, our FDA-cleared concussion assessment tools have equipped thousands of healthcare providers with reliable and objective data to support their clinical decision making and communicate patients’ cognitive status to other members of the multidisciplinary team. ImPACT Applications’ suite of FDA-cleared products include… ImPACT – an online neurocognitive tool for baseline and post-injury testing for ages 12-80. ImPACT Pediatric - an online neurocognitive tool for baseline and post-injury testing for ages 5-11. ImPACT Quick Test – iPad-based screening tool for removal from activity decisions. In addition to improving your workflow and helping you make more informed treatment decisions, you can also increase your reimbursement by $250 or more when using CPT 96132 and including ImPACT or ImPACT Pediatric as part of your concussion evaluation. If you’re looking for concussion care tools, training, or resources. We’ve got you covered. Follow us for daily educational content that will make you a better concussion care provider, and visit ConcussionManagement.com to learn more. #Concussion #ConcussionCare #TBI #SportsMedicine

Neurodiversity Cognitive Assessment Software

InCrowd connects healthcare professionals with quick, paid surveys that respect your time and protect your privacy. Our platform is built for clinicians who want to make an impact offering short, mobile-friendly surveys you can complete whenever it works for you. By sharing your experience, you help inform better decisions in healthcare and contribute to advancements that support patients and providers worldwide.

Neurodiversity Cognitive Assessment Software

CNS Vital Signs provides clinicians and researchers leading edge telehealth and in-clinic neurocognitive and behavioral health assessment technologies enabling clinicians to painlessly and rapidly assess their patient’s brain function so they might have a broader, more objective view of neurocognition or brain & behavioral health status. Clinicians use the CNS Vital Signs assessment to get an immediate read on a patients neurocognitive status, brain and behavioral specialists will many times use CNS Vital Signs in combination with other valid assessments to gain a deeper knowledge and understanding of an individual patients status, then CNS Vital Signs is used to monitor and longitudinally track treatments, interventions, disease progression or health outcomes… with a goal of optimizing brain health and thus academic and vocational potential throughout a lifetime.

Neurodiversity Cognitive Assessment Software

The Do-IT team work with organisations by providing services and packages to support people who may be Neurodivergent (Learning Difficulties and Disabilities). Do-IT work with organisations in the Criminal and Youth Justice System, support organisations (Employability contracts, Health, Charities), Apprenticeship and Training Providers, Schools, Employers and specialist organisations. Do-IT Provide a range of support packages including: The Do-IT Profiler- a software-as-a-service to help identify skills, abilities, strength and weaknesses, monitor and evaluate over time offer support and recommendations based on data analysis at person, group, and organisational levels. Neurodiversity Workplace Profiler – web-based screening tools to support employees and their line managers. Neurodiversity Workplace Assessors Profiler – web based screening tools for Occupational Health, Disability Assessors to use with employees and provide one -to -one support. Disability Confident support – helping to take organisations to become Neurodiversity and Disability Confident at all stages from Committed to Leader status. Workshops–tailored specifically to the organisational context/sector delivered by experts in the field. Webinars –bringing training to line managers, Diversity and Inclusion and Human Resources. Research outputs- including data analysis, predictive analytics, evaluations, resource development. Consultancy services- consulting on processes and procedures relating to neurodivergence/Learning Difficulties and Disabilities and finding solutions to specific needs of the organisation. 'We use big data to change society. We use little data to change a person's life.'​

Neurodiversity Cognitive Assessment Software

Cognistat is a rapid (20 minutes), non-invasive neurocognitive assessment that provides healthcare professionals with leading edge screening technology. Cognistat efficiently assesses cognitive functioning in five major ability areas: language (comprehension, repetition and naming), construction, memory, calculation, reasoning (Similarities and judgement). It generates individual profiles highlighting affected areas of the brain to provide a patient’s functional status, the progression of illness or response to treatment. Cognistat has over 400 peer reviewed scientific publications in Dementia, Stroke, Brain Injury and other neurodegenerative conditions. Research and clinical trials demonstrated the validity and reliability of Cognistat. The Cognistat test is administered to patients via a secured web platform under the recommendation of a healthcare professional. It not only defines cognitive strengths and weaknesses, but also identifies important factors like pain, depression and sleep deprivation that adversely affect cognitive functioning. These conditions can often be treated, leading directly to brain fitness. Cognistat can also provide specific information about the potential impact of medications that can affect brain functioning.

Neurodiversity Cognitive Assessment Software

AI-Powered Mental Health Analytical Platform. Cognitive Apps is a mobile-first solution, backed by science and created for mental health analysis and monitoring, mood and emotions tracking through vocal biomarkers.

Neurodiversity Cognitive Assessment Software

BrainFx, Inc. conducts ongoing and cutting-edge research with digital technology to create clinical, digital assessment tools for healthcare professionals to measure the early and subtle effects of brain disorders on a person's ability to function in real life. With early intervention, health professionals can minimize disability, and improve quality of life. Healthcare systems may reduce the associated professional time and associated costs it takes to get similar information traditionally up to 85 percent. The premier offering is BrainFx 360, (90 to 120 minute), a new, comprehensive, standardized, research-based digital assessment tool that is designed to help health professionals measure the functional impact of mild to moderate brain injury or disorder. BrainFx Assessments are designed for those aged 10 and up with, or at risk of: brain injury, stroke, mental illness, aging, dementia, and other neurological / brain disorders and other conditions with cognitive effects. Designed to assist healthcare teams with the information needed for early detection, diagnosis & treatment of neurological dysfunction, and to assist with clinical decision-making for return to activity. Measuring an individual's brain function means healthcare teams will have comprehensive information available quickly (reports available immediately) to consider for treatment planning and recommendations. BrainFx assessments can also provide a baseline, to be compared at a future date so any declines or improvements in functional skills can be tracked. At BrainFx, we want to make the invisible effects of mild to moderate brain disorders visible.